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Abstract
Receptors of the Eph family of tyrosine kinases and their Ephrin ligands are involved in developmental processes as diverse
as angiogenesis, axon guidance and cell migration. However, our understanding of the Eph signaling pathway is
incomplete, and could benefit from an analysis by genetic methods. To this end, we performed a genetic modifier screen for
mutations that affect Eph signaling in Drosophila melanogaster. Several dozen loci were identified on the basis of their
suppression or enhancement of an eye defect induced by the ectopic expression of Ephrin during development; many of
these mutant loci were found to disrupt visual system development. One modifier locus, reph (regulator of eph expression),
was characterized in molecular detail and found to encode a putative nuclear protein that interacts genetically with Eph
signaling pathway mutations. Reph is an autonomous regulator of Eph receptor expression, required for the graded
expression of Eph protein and the establishment of an optic lobe axonal topographic map. These results reveal a novel
component of the regulatory pathway controlling expression of eph and identify reph as a novel factor in the developing
visual system.
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Introduction
Bi-directional signaling through receptor tyrosine kinases of the
Eph family and their Ephrin ligands contributes to diverse
processes during and after development including the establish-
ment of topographic axon projections in the visual system [1,2],
cell migration [3,4], vascular development [5] and long-term
potentiation [6–8]. Crucial to deciphering the mechanisms by
which this signaling pathway mediates such diverse and complex
processes is a complete catalog of its pathway components.
Substantial progress towards this end has been made by
biochemical approaches [9]. Activation of Eph receptors and
transmembrane B-class Ephrin ligands regulates cytoskeletal
dynamics through the recruitment one of several SH2/SH3
adaptor proteins [10–12] and PDZ-domain proteins [13]. Ras
superfamily GTPase activity [14–16] and crosstalk with other
signaling pathways including MAPK [17,18], PI-3 kinase [19] and
heterotrimeric G proteins [13] are involved. Nonetheless, many
effector molecules may have been missed by these approaches. A
complementary approach, utilizing genetic analysis, offers the
possibility of additional insights into Eph signal transduction. We
have undertaken this approach in D. melanogaster.
The diverse activities and functional redundancy of the large
vertebrate Eph and Ephrin families complicates pathway studies.
The D. melanogaster genome, in contrast, encodes only a single Eph
receptor and Ephrin ligand [20]. Previous work has demonstrated
a conserved role for the D. melanogaster Eph pathway in the
establishment of adult visual system axonal topography [21] and
axon guidance within the mushroom body [22]. Within the visual
system, Eph is expressed in a gradient, reminiscent of its graded
retinal expression required for vertebrate retinotectal map
formation, and controls the dorsoventral patterning of cortical
axons that project centripetally to form the medulla neuropil [21].
Within the olfactory system, Eph is expressed by mushroom body
neurons throughout development and Eph signaling regulates the
guidance of individual axon branches within the mushroom body
[22]. In light of these observations and the diversity of its resources
for genetic analysis, D. melanogaster should serve as a valuable model
system in which to identify novel components of the Eph pathway.
The D. melanogaster eye has often been used as an assay in genetic
screens, including those for components of receptor tyrosine kinase
(RTK) pathways [23–25]. Each ommatidium of the approximately
750 that comprise the compound eye is composed of the same
complement of cells: eight photoreceptor neurons (R-cells) and a
set of non-neuronal accessory cells, which includes lens-secreting
cone cells and pigment cells [26–28]. The photoreceptor neurons
project retinotopically into distinct regions of the optic lobes: R1–
R6 axons terminate in the lamina while R7 and R8 axons
terminate in different layers of the medulla [28]. The finely
ordered structure of the D. melanogaster visual system gives rise to a
neurocrystalline lattice, which is perturbed by changes in cell
numbers, altered cell differentiation or aberrant axon projections.
These types of developmental defects give rise to visible
phenotypes that are well-suited to enhancer/suppressor screens.
We utilized this approach, conducting a genetic screen for
modifiers of an eye defect associated with the ectopic expression
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loci that either enhanced or suppressed this defect were identified.
We also describe the isolation and molecular characterization of
one such gene, reph, which is found to be a novel regulator of Eph
expression in the developing D. melanogaster nervous system.
Materials and Methods
Modifier Screen for Eph Signaling Mutants
The eye phenotype that served ast h eb a s i sf o rt h em o d i f i e r
screen was produced by sevenless2-GAL4, UAS-ephrin.S t a b l e
stocks of sevenless2-GAL4, UAS-ephrin were generated by recom-
bination and balanced over CyO, hereafter referred to as SE
(sevenless2-GAL4, UAS-ephrin), in preparation for the modifier
screen. To match as closely as possible the genetic background
of SE for the screen, sevenless2-GAL4 animals were isogenized
and tested for endogenous modifiers of the SE phenotype; no
endogenous modifiers were present in the isogenized sevenless2-
GAL4 stock.
Isogenized sevenless2-GAL4 males were mutagenized following a
12-hour starvation by transfer to vials containing sucrose-soaked
cotton impregnated with 3 mg/ml of ethyl-nitrosourea (ENU).
After 12 hours of feeding on the sucrose/ENU food source,
mutagenized males were transferred, in two sequential rounds, to
normal food for 4-hour periods to allow for grooming and
removal of external ENU contamination and subsequently mated
with SE females in bottles at a ratio of 5 mutagenized males per
50 SE females. A total of 50 mutagenized males were crossed to
500 SE females. After incubation at 25uC, F1 progeny were
examined for the presence of dominant enhancers or suppressors
of the SE phenotype and scored. Candidate lines were back-
crossed to SE to track the mutation and expand the line.
Mutations were localized to individual chromosomes by subse-
quent crosses to balancer stocks (FM-7 for the X-chromosome,
y
+CyO for chromosome II, Tb/Sb for chromosome III and Ci
D for
chromosome IV) and tracing of segregation of the modifier
phenotype with the balancers. After localization to a particular
chromosome, candidate mutants were back-crossed to SE to
confirm the presence of the modifier mutation in the balanced
stock.
Mapping of Point Mutations to Gene Loci
To identify loci harboring point mutations in the Eph
collection, lethal lines were crossed to chromosomal deficiency
lines (Bloomington Drosophila Stock Center) and assessed for non-
complementation. Successively smaller deficiencies were
screened until the smallest obtainable deficiency-defined non-
complementing region was identified. Next, P-element lethals
within the target region were crossed to the SE modifier lethal
and assessed for non-complementation. For SE modifier lethals
in which available P-element lines failed to resolve the locus,
local P-elements were hopped (see below) to generate a collection
of new regional-specific P-element insertions. These de novo P-
element hops were then individually crossed to the SE modifier
lethal under scrutiny and assessed for non-complementation.
Once a non-complementing line was identified, the locus of
insertion was determined by inverse PCR from the P-element
ends (see below).
P-element Insertional Mutagenesis and Inverse PCR
Analysis of Insertion Loci
Quiescent P-elements were mobilized by crossing target lines
(see below) to flies of the genotype [w
1118; sp/CyO; D2-3,Sb/TM6B]
and incubating at 25uC. In most cases, mobilization of resident P-
elements by the D2-3 transposase involves duplication of the
existing P-element followed by hopping of the duplicated element.
Successfully induced hops therefore manifest themselves in F1
offspring as darker eye pigmentation owing to the presence of two
copies of the w
+ marker carried by the P-element. For
identification of the reph locus two lethal P-element lines,
p[K08617]/CyO and p[K16918]/CyO, localized to a small
deficiency non-complementing to the reph
1 mutant, were used as
starting lines to produce a new collection of local hops. Individual
F1 hops from these lines were crossed directly to balanced reph
1
mutants and assessed for non-complementation. Non-comple-
menting lines were then subjected to inverse PCR analysis to
determine the locus of insertion. For generation of the ephrin
hypomorph, ephrin
RS5,a nRS5 P-element insertion on chromosome
IV [29] was mobilized. Candidate local hops mapping to
chromosome IV were further analyzed by Southern blot of the
ephrin locus. Insertions within the ephrin locus revealed by Southern
blot were then subjected to inverse PCR to determine the precise
location of the P-element insertion.
Inverse PCR was performed essentially as described (E.J. Rehm,
BDGP, http://www.fruitfly.org/about/methods/inverse.pcr.
html), but is summarized here. Flies were homogenized in 16
PBS/0.5 mg/ml Proteinase K (25 ml per fly) in eppendorf tubes,
incubated at room temperature for 30 minutes and subsequently
heat-inactivated at 100uC for 5 minutes. The homogenate was
then spun down and the supernatant collected. 10 ml of genomic
extract was then cut with one of three restriction enzymes: Sau3A I,
HinP1 I or Msp I. Qiagen column-cleaned digests were then
circularized and used as template for PCR under the following
conditions: 406cycles, 3 min extension, 50uC annealing temper-
ature. The following primer pairs were used in the inverse PCR
reactions: A) pLac1 59 CACCCAAGGCTCTGCTCCCACATT
39 & pLac4 59 ACTGTGCGTTAGGTCCTGTTCATTGTT 39
and B) Sp1 59 ACACAACCTTTCCTCTCAACAA 39 & Splac2
59 GAATTCACTGGCCGTCGTTTTACAA 39. Successfully
amplified bands were gel purified using a Qiagen column, sub-
cloned into Topo according to manufacturers’ protocol (Invitro-
gen) and used to transform competent cells. Mini-preps (Qiagen)
obtained from cells transformed with Topo vector containing
inverse PCR inserts were used as template for sequencing
reactions (ABI Prism BigDye Terminator Cycle Sequencing
Ready Reaction Kit). Sequences obtained from inverse PCR
fragments were then BLASTed against the D. melanogaster genome
to identify the site of P-element insertion.
Targeted Homologous Recombination to Generate
Kinase-Dead Eph Animals: DNA constructs and fly crosses
Targeted homologous recombination was performed essential-
ly as described by Rong and Golic [30]. A 6.0 kb EcoRI fragment
of the eph genomic region was first cloned into pBS
(KS).
Subsequently, an I-SceI recognition site was synthesized as two
oligos and cloned into a unique site in exon 6 of the eph gene. The
I-Sce-I modified eph genomic fragment was then cloned into the
Not I site of the P-element vector pP[.w
hs.N.} to produce the
donor construct pP[.w
hs.eph
KD.]f o reph targeting. The donor
construct was then transformed into flies [31]. Recombination
was induced by crossing y
1w
1;[ d o n o r ] / y
+CyO;[ 7 0 FLP], [70 I-
Sce1]/TM3,Sb,e flies to y
1w
67c23 flies and heat shocking. Progeny
were then screened for w
+CyO or changed w
+ eye color and test-
crossed to map the w
+ marker. Animals with w
+ mapping to the
chromosome IV were examined via Southern blot to verify the
targeting event.
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Kinase-Dead Eph Animals: Molecular Analyses of
Targeting Efficacy
Southern blot analyses were performed according to standard
protocols [32] using probes targeting the I-Sce-I cut site of the
donor construct. In addition, RT-PCR experiments were
performed on mRNA isolated from putative eph
KD animals to
verify the presence of predicted truncated transcripts.
Generation and misexpression of P[UAS-reph] and P[UAS-
ephrin] transgenes
A2k bEcoRI/XhoI fragment of reph containing the entire coding
region for the 401 amino acid isoform was excised from a pOT2
cloning vector (GH05923, Drosophila Genomics Resource Cen-
ter, Indiana University) and inserted into the transformation
vector pUAST [33] to generate P[UAS-reph]. Likewise, for P[UAS-
ephrin], the full-length coding region was amplified by PCR and
inserted into pUAST. Transformation of D. melanogaster was
performed as described by Rubin and Spradling [31]. Patterned
expression of the P[UAS-reph] and P[UAS-ephrin] transgenes was
accomplished using the UAS-GAL4 system [33]. All crosses were
grown at 25uC and immunohistochemical analyses performed on
late third instar larvae. The following crosses were used: (A)
y,hsFLP122;;UAS-reph X y,w; UAS-CD8::GFP, tuba1.y
+, CD2.GAL4/
y
+CyO, (B) sevenless2-GAL4 X UAS-ephrin, (C) sevenless2-GAL4, UAS-
ephrin/y
+CyO X UAS-reph (‘.’ indicates the position of an FRT site
in the respective construct).
Mosaic Analysis of reph function in the Developing Optic
Lobe
Mosaic analysis was carried out as described by Xu and Rubin
[34]. Larvae were subjected to heat shock at 37uC for 60–
75 minutes 24–36 hours after hatching to induce expression of an
hsFLP transgene. After growth at 20uC, larvae were dissected at
late larval third instar stage and processed for immunohistochem-
ical analysis. The following crosses and strains were used in the
experiments described: y,hsFLP122;P { arm-lacZ}42D,
P{FRT}42D/P{y
+},CyO X y,w;P { lacW}reph, P{FRT}43D/
P{y
+}, CyO
Immunocytochemistry
Immunocytochemically staining was performed essentially as
described in [35]. Primary antibodies were used at the following
dilutions: rabbit anti-Eph 1:200 [21], rabbit anti-Ephrin 1:200
[36], goat FITC or Cy3 anti-HRP (Cappel) 1:200, mouse anti-bgal
(Promega) 1:100. Secondary antibodies were used at the following
dilutions: Cy3 or Cy5 goat anti-mouse (Jackson Immunochemical,
Inc.) 1:100, Cy3 or Cy5-goat anti-rabbit (Jackson) 1:500, HRP-
conjugated goat anti-mouse IgG (Jackson) 1:100. Specimens were
viewed on a Zeiss LSM510 META confocal microscope.
RNA localization by tissue in situ hybridization
In situ hybridization was performed on larval third instar
specimens as referenced in [21]. A pOT2 vector containing a full-
length reph cDNA (GH05923, Drosophila Genomics Resource
Center, Indiana University) was used as template to prepare both
sense (BglII linearized, Sp6 RNA polymerase transcription) and
antisense (XhoI linearized, T7 RNA polymerase transcription)
digoxigenin-labeled probes (Riboprobe Combination System-
Sp6/T7, Promega). Hybridized specimens were developed
following incubation with anti-digoxigenin-alkaline phosphatase
conjugated antibodies (mouse anti-digoxin, Sigma). Bright-field
images were captured with a CCD camera.
Results
Eph and Ephrin Expression Patterns in the Developing
Visual System
We have previously shown that the Eph protein is expressed on
the axons of photoreceptor neurons, medulla and lobula cortical
neurons and the membranes of lamina neuron precursors. The
medulla cortex and axonal projections establish a three-dimen-
sional neuropil that provides topographically arrayed synaptic
targets for R7 and R8 photoreceptor axons and lamina axons. Eph
antigen on medulla axons displayed a dorsoventral gradient, high
at the midline toward the dorsal and ventral poles (Figure 1; [21]).
Moreover, we found that disturbing this gradient resulted in
topographic medulla axon targeting defects [21]. In contrast, Eph
antigen on photoreceptor axons appeared uniform across the
dorsoventral axis of their retinotopic projections into the brain.
The D. melanogaster genome also encodes a single Ephrin
ortholog, which is most similar to vertebrate Ephrin B class ligands
[36]. While RNAi interference approaches have suggested a role
for Eph/Ephrin signaling in neuronal development, notably
within the embryonic CNS [21,36], analyses of Eph null mutants
did not detect embryonic CNS defects but rather a specific role for
Eph/Ephrin signaling in the developing mushroom body [22].
The disparity between these results suggests a complex role for
Eph/Ephrin signaling during Drosophila development that would
benefit from additional characterization, specifically analyses of
Ephrin expression patterns within the larval brain.
Like Eph, the expression of its ligand Ephrin was uniform across
the dorsoventral columns of ommatidia posterior to the morpho-
genetic furrow (Figures 1-B2 and 1-C2). Within the lamina, retinal
axons distribute themselves retinotopically along the dorsoventral
and anteroposterior axes, forming a crescent-shaped target field
(Figure 1-A1 and 1-A3). Retinal axons arrive in this field in a
posterior to anterior temporal order, in concert with the temporal
dynamics of photoreceptor cell differentiation in the retina. The
axons from each dorsoventral column of photoreceptor neurons
arrives in the target field contemporaneously, and distribute
themselves retinotopically on the dorsoventral axis of the lamina.
Eph expressed on the membranes of developing lamina neurons
displayed gradients on both axes; high dorsoventral midline and
high posterior to low anterior (Figure 1-B3; [21]). Ephrin
expression, in contrast, appeared relatively uniform (Figure 1-
C3). In the medulla ganglion, the target for R7/R8 photoreceptor
axons, cortical axons project topographically into a crescent-
shaped neuropil, which requires cues conveyed by the pattern of
Eph expression [21]. As was the case for the developing eye disc,
Eph and Ephrin were expressed in similar gradients on axons of
medulla cortical neurons—high midline, low dorso-ventral
(Figures 1-B5 and 1-C5, respectively). Co-expression of Eph
receptors and Ephrin ligands has been observed in a number of
tissues [22,37,38] and suggests that the mechanism by which Eph/
Ephrin signaling regulates axon guidance is more complex than
simple gradient-mediated interactions. Such co-expression would
permit both forward and reverse signaling within the same cell, as
well as for both trans and cis regulation of Eph/Ephrin complexes
[39]. Thus, the effects of Eph/Ephrin signaling within a given cell
may depend on the coordination of these various regulatory
possibilities. Given the extensive expression of Eph and Ephrin in
the larval third instar visual system (summarized in Figure 1D) and
observations that disruption of Eph expression affects axon
topography [21] we reasoned that the developing D. melanogaster
visual system might provide an amenable model to screen for
components of the Eph/Ephrin signaling pathway.
Reph, a Regulator of Eph Receptor Expression
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Components
We have previously shown that misexpression of a UAS-eph
+
transgene disrupts optic lobe development [21] and reasoned that
such transgene-mediated phenotypes might manifest as observable
defects in the adult eye. After a survey of GAL4 driver and
transgene combinations, we determined that the moderate rough
eye phenotype of sevenless2-GAL4, UAS-ephrin
+ (hereafter referred to
as SE; Figure 2B) animals was best suited for a modifier screen.
The SE adult eye defect exhibited little variation of penetrance
and was suppressed by co-expression of a dominant-negative eph
transgene (Figure 2C) or by the eph
KD mutation (data not shown).
In the former case, we reason that co-expression with an excess of
a kinase-inactive Eph isoform would bind up ectopic Ephrin,
suppressing its signaling activity. In the latter case (eph
KD, see
Figure 3), the eph
+ locus was targeted by homologous recombina-
tion to yield a kinase-defective mutant allele. In the absence of a
functional Eph kinase, ectopic Ephrin expression had no effect on
adult eye morphology. These observations indicate that the SE
morphological phenotype is due to ectopic activation of the Eph
pathway.
As a preliminary test of the SE background in detecting modifier
mutations, deficiency lines representing all four D. melanogaster
chromosomes (Bloomington Drosophila Stock Center) were sur-
veyed for genetic interaction with SE. A total of 196 deficiency
lines were screened representing approximately 43% of the D.
melanogaster genome. Approximately two-dozen enhancers and
suppressors of the SE rough eye phenotype were identified by this
approach, which gives an estimate of 50–55 interacting loci across
the entire genome. To identify point mutations that acted as
modifiers, ENU mutagenized animals were crossed into the SE
background and the F1 progeny examined for enhancement or
suppression of the SE eye phenotype (see Materials and Methods).
Approximately 15,000 F1 progeny were screened in this manner;
52 lines were retained to form a collection of candidate mutants.
This collection includes 24 enhancers (13 recessive lethals) and 28
suppressors (11 recessive lethals; see Figure 3D). On the basis of
chromosomal location and complementation analysis the 52
mutants were found to define 40 loci, which should represent
Figure 1. Eph and ephrin expression patterns in the D. melanogaster larval third instar optic lobe. A1–A5) anti-HRP staining (green)
reveals overall optic lobe architecture. Posterior to the morphogenetic furrow (MF), retinal axons of ommatidia (small circles, A1) in the developing
eye disk (ED; A2) project through the optic stalk (OS; A2) to topographically innervate two target regions in the brain: the lamina (Lam; demarcated by
the lamina furrow, LF; A3) and the medulla (A5), which lies proximal to the lamina. Axons of medulla cortical neurons (Med cortex; A5) also project
topographically to form a crescent-shaped neuropil (Med n’pil; A5). Schematic representations of optic lobe architecture are shown in A1 (eye and
lamina) and A4 (medulla). B1-B5) anti-Eph staining (grayscale). Across the ED, Eph expression appears uniform posterior to the MF. Within the Lam,
Eph expression is highest at the posterior midline and lowest at the dorsal-ventral margins of the anterior (B2, B3; depicted schematically in B1).
Within the medulla, Eph expression is again highest at the midline, diminishing along the dorsal-ventral axis (B5; depicted schematically in B4). C1–
C5) anti-Ephrin staining (grayscale) reveals uniform expression of Ephrin across the developing ED (C2). Within the Lam Ephrin expression appeared
relatively uniform (C3). Ephrin-specific expression patterns in the developing ED and Lam are depicted schematically in C1. Within the medulla, Ephrin
expression mirrors that of Eph: highest at the midline, diminishing along the dorsal-ventral axis (C5; depicted schematically in C4). D) Summary of
Eph/Ephrin expression patterns in the developing visual system (horizontal perspective, which depicts the spatial relationship of the lamina and
medulla target fields). Anterior (red arrow) and dorsoventral margins (yellow arrows) are indicated. All image panels were of late third larval instar
stage brains stained for HRP (anti-HRP, A2, A3, A5), Eph (anti-Eph, B2, B3, B5) or Ephrin (anti-Ephrin, C2, C3, C5). Note that A2, B2, and C2 are the same
image for which individual channels have been displayed. All other images represent distinct specimens. Dorsal (D), ventral (V), anterior (A) and
posterior (P) orientations (central compass) are identical for all panels.
doi:10.1371/journal.pone.0037303.g001
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Eph and Ephrin mutants in the characterization of
modifier mutations
As a step toward clarifying the developmental roles of candidate
genes that function in the Eph/Ephrin signaling pathway(s), we
undertook mutagenesis of the eph and ephrin loci to generate loss-of-
function alleles that could be used to establish genetic interactions
with the modifier mutations. The eph and ephrin loci are located on
chromosome IV, a small chromosome predicted to harbor about
81 genes. For eph, the homologous targeting method [30] was used
to introduce a deletion of the kinase domain into the coding
region, to create eph
KD. For ephrin, we utilized local transposition to
introduce a transposon into the 59 end of the gene. The eph
KD
mutation is predicted to be a partial loss-of-function allele, which
still retains reverse-signaling and kinase-independent activities.
Consistent with this notion, truncated transcripts were expressed
in eph
KD mutants (Figure 3 C) while eph
KD phenotypes (Figure 3E)
were less severe than those elicited using RNAi [21]. The eph
KD
mutation also resulted in increased developmental mortality and
female sterility, indicative of requirements for Eph function outside
of the optic lobe. The ephrin
RS5 mutation also appeared to be a
partial loss-of-function allele exhibiting a robust reduction, but not
absence of, Ephrin expression (Figure 3H).
The strategy used to generate an Eph receptor mutant with a
deleted kinase domain (eph
KD) is depicted in Figure 3A. The
‘donor’ construct generated a tandem partial duplication by ‘ends-
in’ recombination to produce one untranslatable copy of eph and
one translatable copy bearing a 39 deletion encompassing the
entire kinase domain. A total of five independent strains were
recovered that displayed mobilization of the donor w
hs gene
(Figure 3B). Of these five candidates, three mapped to chromo-
some IV and were demonstrated to have targeted the eph locus by
Southern blot analysis. To confirm replacement of endogenous eph
with the eph
KD isoform, RT-PCR analysis of mRNA transcripts
from the eph
KD 1, 2 & 4 lines was performed (Figure 3C).
Truncated transcripts predicted to encode the kinase-deleted Eph
isoform were detected (Figure 3C), whereas full-length eph
transcripts were not. Eph immunoreactivity was not detected in
eph
KD animals (compare Figures 3D9 and 3E9) by an anti-Eph
antibody generated against a C-terminal peptide [21], which
would be deleted in eph
KD.
Signaling via the Eph receptor (or ‘forward signaling’) should be
abolished in the eph
KD mutant, but ‘reverse signaling’ [40] via the
transmembrane Ephrin, whose conserved cytoplasmic tyrosine
phosphorylation site is consistent with intracellular signaling
functions [36], would still be possible. Homozygous animals
displayed reduced viability, with an approximately 50% develop-
mental mortality. Survivors displayed normal external adult
morphology. Homozygous eph
KD females exhibited a 60%–90%
rate of sterility. Olfactory-based learning in eph
KD animals was also
significantly impaired (A. Szybowski and S. Kunes, unpublished
observations). Eph signaling is required for normal development of
the mushroom body [22], where olfactory learning occurs.
Although adult eye structure and gross retinal development were
normal in eph
KD animals (data not shown), at the third larval instar
stage, when axonal topography is elaborated in the developing
adult visual system (Figure 1), eph
KD animals displayed variable
defects in the centripetal projections of medulla cortical axons
toward the developing neuropil (Figure 3E). These defects
appeared similar in nature, albeit less severe, to those that resulted
from reduction of Eph expression via RNA interference [21]. The
eph
KD animals displayed gaps in the crescent-shaped neuropil and
ectopic axon bundles in the cell body layer surrounding the
neuropil (Figures 3E and 4E).
To generate a mutation at the ephrin locus, we employed local
transposition of the P transposon RS5 [29] located adjacent to the
ephrin locus. The ephrin locus was found to be extraordinarily
refractory to P-element insertion; however, one local insertion,
Figure 2. A genetic screen for Eph pathway signaling molecules. A) The wild-type adult eye displays a regular ommatidial lattice. B) The
rough-eye phenotype generated by expression of UAS-ephrin under control of the sevenless2-GAL4 driver (SE) used to screen for modifier mutations.
C) Near-complete suppression of the SE phenotype by co-expression of a dominant-negative eph transgene (eph
DN). D) Suppression of the SE
phenotype by the reph
1 allele. E) Suppression of the SE phenotype by reph
k8617. F) Co-expression of a UAS-reph
+ transgene enhances the SE
phenotype. All images (206) were acquired through a digital camera attached to a Zeiss Stemi SV11 stereo dissecting microscope. Images were
captured using FPG3 software.
doi:10.1371/journal.pone.0037303.g002
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black=coding sequences) and 13 introns (lines), localized to the 102D2-D5 region of chromosome IV. The core donor construct (see Methods for
details) consisted of eph genomic sequences (blue) lacking exons 1–4 (deleting the 59UTR, start codon, signal sequence and a portion of the
exoplasmic domain) and a 39 region lacking the kinase domain and terminal 39 sequences. An I-SceI site was engineered into the middle of exon 6
(red shading). The core construct was placed upstream of a white gene marker (w
hs, green shading), the whole being bracketed by FLP recognition
target sequences (FRT, purple shading) and inserted into the transformation vector. ‘Ends-in’ recombination induced by FLP and I-SceI resulted in
partial tandem duplication of the eph locus (bottom-most diagram). B) Southern blot analysis of five candidate eph
KD targeting events. Lane 1:
molecular weight markers. Lanes 2–8: NotI digests of genomic DNA derived from: L2 (Canton S, control), L3 (Donor line, control), L4 (eph
KD1), L5
(eph
KD2), L6 (eph
KD3), L7 (eph
KD4) and L8 (eph
KD5). The lower molecular weight band (non-mobilized donor construct) was absent from eph
KD lines 1, 2
& 4 indicating successful homologous recombination. Lanes 9–15: BglII digests of genomic DNA derived from: L9 (Canton S, control), L10 (Donor line,
control), L11 (eph
KD1), L12 (eph
KD2), L13 (eph
KD3), L14 (eph
KD4) and L15 (eph
KD5). The convergence of distinct donor and endogenous eph bands into a
single band due to homologous recombination is clearly evident in the eph
KD1, 2 & 4 lines (L11, L12 and L14). C) RT-PCR using primers for the full-
length eph transcript (L1–9, left side of gel and left diagram; primer locations indicated by arrows). L1 (Canton S, control), L2 (Donor line, control), L3
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RS5, was obtained that disrupted the 59 UTR of the ephrin
mRNA (Figure 3F). The homozygous mutant animals were viable,
with normal external adult morphology. They exhibited approx-
imately a 50% reduction in ephrin transcript level, as determined by
quantitative RT-PCR analysis (data not shown). In wild-type
animals, Ephrin is found in puncta on the axons of medulla
cortical neurons, and concentrated within the neuropils of the
medulla and lobula (Figures 1-C5 and 3G9). Ephrin protein was
substantially reduced in the optic lobe of ephrin
RS5 homozygotes
(Figure 3H9). While these animals displayed normal ommatidial
development (data not shown), subtle defects in optic lobe axonal
topography were observed (Figure 3H, arrowheads). In the
medulla, cortical axon misprojection resulted in neuropil gaps
and ectopic axons in the cortical cell body layer. Photoreceptor
axon projection defects were observed in the lamina, but these
misprojections appeared correlated with defects in medulla
architecture. The similarity of the ephrin
RS5 hypomorphic pheno-
type with that of eph
KD is consistent with the notion that these
proteins act in the same pathway. However, we must note that
many unrelated activities contribute to medulla development and
can yield superficially similar axon projection phenotypes.
Although the anti-HRP staining used in these studies doesn’t
reveal specific aspects of the optic lobe defects associated with
eph
KD and ephrin
RS5 mutations, such as axon subsets or expression of
cell adhesion molecules, it provides useful categorization based on
general architectural features. To better assess and characterize
these medulla phenotypes, eph
KD and ephrin
RS5 animals were scored
based on the following criteria: the presence of gaps in the medulla
neuropil (0, 1 or .1), the degree of lobula neuropil disruption
(none, mild, moderate, or severe) and the presence of HRP
+
cortical inclusions (yes or no). For eph
KD mutants (n=16) all
exhibited at least one gap in the medulla neuropil with the
majority (75%, 12/16) showing more than one such gap. Half of
these animals had normal lobula architecture with 38% (6/16)
exhibiting mild disruption and only 12.5% (2/16) having
moderate-level defects. Large HRP
+ cortical inclusions were rare,
with only 12.5% (2/16) of eph
KD mutants exhibiting this feature.
Notably, the ephrin
RS5 phenotype appeared qualitatively different
based on the aforementioned criteria. In the specimens examined
Figure 4. reph interacts genetically with the eph
KD and ephrin
RS5 mutations. In wild-type flies (A, E) the medulla neuropil (med) is
distinguished by its regular crescent shape (anti-HRP staining, grayscale, all panels A–H). Mutant phenotypes could be broadly categorized as defects
in the medulla neuropil (white arrowheads), HRP+ cortical inclusions (yellow arrowheads) or disruption of lobula (lob) architecture (red arrowheads).
In homozygous ephrin
RS5 mutants (B), subtle abnormalities were observed in the medulla neuropil and cortex. The severity of ephrin
RS5 medulla
defects was enhanced by a single copy of reph
1 (C) or reph
K8617A (D). In homozygous eph
KD mutants (F) gaps in the medulla neuropil were often
present. A single copy of the reph
1 allele (G) or reph
K8617A (H) exacerbated the eph
KD mutant phenotype.
doi:10.1371/journal.pone.0037303.g004
(eph
KD1/eph
KD1), L4 (eph
KD1/+), L5 (eph
KD2/+), L6 (eph
KD2/eph
KD2), L7 (eph
KD4/+), L8 (eph
KD4/eph
KD4), L9 (eph
KD3/eph
KD3), L10 (molecular weight
markers). Full-length transcript was not detected in eph
KD homozygous animals (26 cycles). RT-PCR using primers for the 39-deleted isoform of Eph is
shown in L11–L19, right side of gel and right diagram (primer locations indicated by arrows). Source RNA for L11–L19 was identical to L1–L9. Only the
truncated Eph isoform was expressed in eph
KD animals. Abbreviations: LBD (ligand-binding domain), FNIII (fibronectin type III repeats), JXM
(juxtamembrane region), TK (tyrosine kinase domain), SAM (sterile alpha motif), PDZ (postsynaptic density 95/Discs-large/zona occludens-1 domain).
D,D9) Eph (anti-Eph, red in D, shown alone in D9) is expressed on cortical neuron axons in wild-type third instar larvae, accumulating in a high-midline
low-dorsoventral gradient in the medulla neuropil (compare anti-HRP staining, green, to anti-Eph staining, red). E,E9) Lack of Eph immunoreactivity
(anti-Eph, red in E, shown alone in E9) corresponded to optic lobe defects (anti-HRP, green) in eph
KD animals, manifest as gaps in the neuropil
(arrowheads). F) Schematic of the 5.8 kb ephrin locus localized to the 102C2 region of chromosome IV. The ephrin gene is comprised of 5 exons (black
boxes) and 4 introns (gray lines). The start codon (red arrow) and RS5 P-element insertion site (red shaded box) into 59UTR of the first exon are also
indicated. G,G9) In wild-type animals, Ephrin expression (anti-Ephrin, red in G, shown alone in G9) is punctate along cortical neuron axons and
concentrated in the optic lobe neuropil (anti-HRP, green in G). H,H9)I nephrin
RS5 mutants, Ephrin expression is considerably reduced in the optic lobe
(anti-Ephrin, red in H, shown alone in H9), resulting in neuropil defects (arrowheads; anti-HRP, green in H). White or yellow bars indicate the
dorsoventral midline. Scale bar in D is 20 mm for D,D9,E,E9, G,G9, H,H9.
doi:10.1371/journal.pone.0037303.g003
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neuropil, while 65% (11/17) had no gaps. Disruption of lobula
architecture was more common in ephrin
RS5 animals—24% (4/17)
exhibited moderate defects and 47% (8/17) showed mild defects.
As was the case with eph
KD mutants, large HRP
+ coritical
inclusions were rare in ephrin
RS5 mutants, with only 6% (1/17) of
the specimens manifesting this phenotype. Thus, the eph
KD
phenotype was generally characterized by multiple gaps in the
medulla neuropil with relatively normal lobula development, while
the ephrin
RS5 phenotype was somewhat reversed with a higher
percentage of normal medulla development and a greater degree
of lobula disruption relative to eph
KD mutants. Such qualitative
categorization served as a baseline for assessing genetic interac-
tions between modifier mutations and the eph
KD and ephrin
RS5
mutants.
The SE suppressor mutation, reph, interacts with ephrin
and eph mutations
Mutations in genes that participate in Eph/Ephrin signaling
should disrupt optic lobe axonal topography as observed when eph
expression patterns or levels are altered ([21] and below). Such
mutations might also have additional distinct phenotypes, as a
consequence of the gene’s pleiotropic or tissue-specific functions
outside of the Eph pathway. The lethal SE enhancers and
suppressors displayed a range of temporal lethality, spanning early
embryogenesis to late pupation. We examined visual system
architecture in homozygous viable and late-lethal mutants at the
late third instar larval stage, the time of visual system axon
outgrowth and topographic patterning. Of eleven modifier
mutations representing distinct loci that were examined at this
stage eight displayed defects in medulla architecture (data not
shown) roughly similar to eph and ephrin mutants (Figures 3E and
3H).
Since the criterion of optic lobe developmental defects was
insufficient in and of itself to identify a given enhancer or
suppressor as a component of the Eph/Ephrin signaling pathway,
we sought to establish genetic links. To identify modifier mutations
that interacted with the Eph/Ephrin pathway in the establishment
of axon topography, we screened the mutant collection for
suppression or enhancement of the ephrin
RS5 and eph
KD mutant
phenotypes (Figures 3E, 3H). This strategy identified an SE
suppressor, which we have named reph (regulator of eph expression,
see below) as a strong interactor with Eph pathway function.
reph
1 and reph
K8617A were strong suppressors of the SE
phenotype, a phenotype induced by ectopic Eph pathway
activation (Figure 2). In contrast, heterozygosity for either the
reph
1 or reph
K8617A alleles enhanced the optic lobe axonal targeting
phenotypes of the ephrin
RS5 or eph
KD homozygotes (Figure 4), while
reph
1 or reph
K8617A heterozygosity in an otherwise wild type
background displayed normal optic lobe development. All of the
phenotypic features associated with the eph
KD were exacerbated by
the presence of the reph alleles. In the reph
1/+; eph
KD/eph
KD
specimens examined (Figure 4G, n=10), 80% (8/10) had multiple
gaps in the medulla neuropil and all exhibited some form of lobula
disruption, 50% (5/10) of these being severe (e.g. multiple gaps,
misprojections, etc.). Furthermore, large HRP+ cortical inclusions
were frequently observed (8/10 of the specimens examined). For
the reph
1/+; ephrin
RS5/ephrin
RS5 genotype (Figure 4C, n=5), 80%
(4/5) exhibited multiple gaps in the medulla neuropil, 80% (4/5)
had large HRP+ cortical inclusions, and 80% (4/5) mild to
moderate disruption of lobula architecture. Similar phenotypes
were observed for the reph
K8617A allele, confirming that the genetic
interaction could be attributed to the reph mutations and not the
genetic background of the lines. As was the case for reph
1,
reph
K8617A/+; eph
KD/eph
KD specimens (Figure 4H, n=7) exhibited
multiple gaps in the medulla neuropil (86%, 6/7), increased lobula
disruption (57% or 4/7 being severe) and large HRP+ cortical
inclusions (86% or 6/7 of the specimens examined). Likewise, for
the reph
K8617A/+; ephrin
RS5/ephrin
RS5 genotype (Figure 4D, n=5),
80% (4/5) exhibited multiple gaps in the medulla neuropil, 60%
(3/5) had large HRP+ cortical inclusions, and 80% (4/5) mild to
moderate disruption of lobula architecture. Taken together, these
data were consistent with reph functioning within the Eph/Ephrin
signaling pathway.
Molecular characterization of the reph locus
To gain insight into the role of reph in the Eph/Ephrin pathway,
we undertook a molecular characterization of the reph locus. We
used deficiency mapping and complementation with P-element
lethal insertion mutations to localize reph
1 to Df(2L)sc19-8, which
spans a small region (24C2-24D2) that contains only 13 predicted
genes. Like reph
1, a chromosome bearing Df(2L)sc19-8 suppressed
the SE rough eye phenotype. The P-element insertion
P[lacW]l(2)k16918
k16918, one of four lethal insertions uncovered
by Df(2L)sc19-8, displayed semi-lethality over the reph
1 mutant
chromosome. DNA sequencing mapped P[lacW]l(2)k16918
k16918
to the reph locus, revealing that the P[lacW]l(2)k16918
k16918
insertion was indeed a reph allele, which was designated reph
k16918
(Figure 5A). To generate additional P-element insertions within
reph, we mobilized a second insertion in the Df(2L)sc19-8 region,
P[lacW]bowl
k8617,and obtained one reph
1 non-complementing
insertion, named reph
k8617A (Figure 5A). Rescued DNA sequence
flanking the reph
k8617A insertion matched the predicted locus,
CG3920 (Flybase). The reph
k8617A allele also suppressed the SE eye
phenotype as a reph
k8617A/+ heterozygote (Figure 2E).
The reph locus is predicted to encode two mRNAs via alternative
splicing (Figure 5A). reph
k8617A is an insertion within the first intron
of the 2.1 kb transcript, upstream of the first exon of the reph
3.1 kb transcript. The reph
k16918 insertion is located 1.3 kb
downstream of reph
k8617A within the 59UTR of the 3.1 kb reph
transcript. As a final test of the identity of reph and CG3920, we
examined rescue with a UAS-reph
+ transgene (see below). Pan-
neural expression of UAS-reph
+ with the driver elav-GAL4 [41]
rescued the homozygous lethality of reph
1, consistent with a
requirement in the nervous system. Given that eph null alleles are
viable [22] these data suggest that reph has additional functions
unrelated to the regulation of eph. In addition, SE animals
harboring a single copy of UAS-reph
+, under sevenless2-GAL4
control, displayed a more severe (enhanced) SE eye phenotype
(Figure 2F). These data permit the conclusion that reph is the
CG3920 locus.
The predicted reph transcripts encode proteins of 351 and 401
amino acids, which differ in their translation initiation sites
(Figure 5B). Reph lacks robust homology to known proteins,
although database searches indicate weak similarities between
Reph and a variety of transcription factors. An example of such
homology to a region of the human SPOC (Spen paralog and
ortholog C-terminal) domain-containing 1 protein is shown in
Figure 5C. SPOC domain-containing proteins are nuclear
effectors of receptor tyrosine kinase signaling in Drosophila nervous
system development [42–44]. Although not itself a member of the
SPOC family, Reph harbors a nuclear localization signal
sequence, consistent with a putative role in transcription
(Figure 5B). Although it lacks any other conserved domain
features, the overall structure of Reph may be related to the
IMP dehydrogenase/GMP reductase family; the significance of
this structural similarity is unclear. Given the limited utility of
Reph, a Regulator of Eph Receptor Expression
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37303sequence analysis in revealing reph’s developmental role, we turned
to more functional studies.
reph expression in the larval third instar visual system
Developmental expression patterns of reph were analyzed via
lacZ expression from the two P[lacW] enhancer trap insertions and
by in situ hybridization. Reporter expression was found in the eye,
lamina, and medulla of the developing visual system at the late
third instar stage in patterns overlapping that of Eph (Figure 6).
Like Eph, reph expression in the eye disc was most pronounced
posterior to and within the morphogenetic furrow (Figure 6A9).
Within the lamina, reph and Eph expression were highest at the
posterior midline, diminishing in a graded fashion along the
dorsoventral axis (Figures 6C and 6C9). Within the medulla, reph
expression was similar to Eph, most notably expressed within the
Eph-positive cell bodies of the cortex, where cytoplasmic b-
galactosidase normally accumulates (Figure 6D9). Within these
cortical cells, both reph and Eph expression were lowest at the
dorso-ventral margins (Figures 6D9 and 6D0, yellow arrowheads).
Thus, the graded pattern of reph expression in the medulla
corresponds to the graded pattern of Eph expression. Additional
reph expression was found in the lobula where Eph-expressing cells
border the posterior face of the medulla (Figures 6D9 and 6D0).
Reph lacZ expression was additionally examined in the embryonic
CNS, where it over-lapped the expression of Eph (data not shown).
In situ hybridizations using reph-specific probes were also
performed on larval third instar brains (Figures 6E and 6F).
Although the resolution was low, in situ hybridization showed
similar expression patterns as for the lacZ reporter lines. Within the
eye disc reph expression was found in cells posterior to and within
the morphogenetic furrow (Figure 6F). Although lacZ expression
appeared more uniform posterior to the morphogenetic furrow
compared with RNA expression, this may be a consequence of b-
galactosidase perdurability. In the optic lobe, at regions proximal
to the lamina, reph expression was highest at the midline (Figure 6F)
Figure 5. Reph encodes a putative nuclear protein. A) The reph
1 allele, reph
k8617A, was mapped by inverse PCR to the CG3920 locus, which
harbors another P-element insertion l(2)k16918 (reph
k16918). The reph locus spans 5.5 kb and encodes two alternatively spliced transcripts of 2.1 kb
and 3.1 kb. Exons are indicated by boxes and introns by connecting lines. The insertion sites for reph
k8617A (first intron of the 2.1 kb transcript) and
reph
k16918 (59UTR of exon 1 of the 3.1 kb transcript) are indicated on the GenBank scaffold sequence (AE003578) by red triangles. B) The 3.1 kb
transcript is predicted to encode a protein 401 amino acids in length, while the 2.1 kb transcript a protein of 351 amino acids that differ only in the
site of translation initiation (red arrow). A conserved nuclear localization signal sequence is indicated by the blue-shaded box. C) Reph shows weak
similarities to several transcription factors although with no obvious homologs. An alignment to amino acids 361–451 of the human SPOC-D1
transcription factor (NP 653170) is shown as an example (32% identity, 67% similarity over this stretch).
doi:10.1371/journal.pone.0037303.g005
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together, these observations place Reph in the appropriate
spatiotemporal context to function in the Eph signaling pathway.
reph is necessary and sufficient for Eph expression in the
developing CNS
Animals homozygous for any of the three reph alleles failed to
survive embryogenesis. These embryos were examined for the
Figure 6. reph expression correlates with Eph expression in the developing optic lobe. Expression patterns for reph in the developing
retina, lamina and medulla were determined using a lac-Z reporter associated with reph
k8617A and by in situ hybridization. Staining for HRP (anti-HRP,
green, A,C,D) was used to visualize general cellular architecture. In the developing retina, reph (anti-b-gal, red in A, shown alone in A9) was expressed
primarily in cells within and posterior to the MF, which correlated well with Eph expression (anti-Eph, B). In the lamina, reph was expressed in a high-
midline, low-dorsoventral gradient (C9, demarcated by yellow arrowheads), as was the case for Eph (C0). In the medulla, reph expression within cortical
neurons diminished at the dorsoventral margins (D9, yellow arrowheads) as was the case for Eph expression (D0). In situ hybridization (controls are
shown in E) supported the lacZ reporter data. In the developing retina reph expression was found in cells within and posterior to the MF, while within
the lamina region reph expression was highest at the midline (F, yellow arrowheads). Abbreviations: cortex (ctx), eye disc (ED), lamina (lam), lobula
(lob), medulla cortex (med c), medulla neuropil (med n), morphogenetic furrow (MF).
doi:10.1371/journal.pone.0037303.g006
Reph, a Regulator of Eph Receptor Expression
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e37303expression of Eph in the ladder-like neuropil of the thoracic and
abdominal segments. Eph expression was absent, and frequent
defects in the ladder-like organization of commissural and
longitudinal connectives were observed (data not shown). Howev-
er, such defects were not observed in eph
KD mutants or in eph null
mutants [22], which were usually viable. These observations
suggest roles for reph both in the regulation of Eph expression and
in additional activities required for embryonic CNS development
and viability.
In the lamina, Eph is expressed in a gradient, highest in the
posterior and lowest at the anterior and dorso-ventral margins
(Figure 7A0). Loss of reph activity in somatic reph
k8617A clones
(Figure 7B, n=35) reduced Eph expression in the mutant cells
(Figure 7B0), but not in their wild type neighbors. Photoreceptor
axon projections near such clones were abnormal (red arrows,
Figure 7B9) and the lamina furrow failed to extend ventrally
through the clone (read arrowhead, Figure 7B9). We considered
whether the loss of Eph in the lamina (Figure 7B0) might reflect
failure of lamina precursor cells to differentiate [45] by staining
reph
k8617A somatic clones for the early differentiation marker
Dachshund (Figure 7C0 and [46]). In reph
k8617A somatic clones
(n=7) Dacshund was expressed normally (Figure 7D0), although
lamina furrow and photoreceptor projection defects were
observed. These data indicated that reph acts downstream of
lamina induction.
Conversely, we examined whether reph
+ activity was sufficient
for Eph expression by using the UAS, GAL4 system [33] to drive
ectopic expression of a reph
+ transgene encoding the 401 amino
acid isoform of Reph (see Materials and Methods for details).
Whether the smaller (351 amino acid) Reph isoform differs in
activity and/or function remains to be examined. Eph is expressed
in subsets of developing neurons; within the medulla, the graded
pattern of Eph expression (high midline, low dorsoventral) is
particularly notable (Figure 8 A0). We first examined how driving
uniform reph
+ expression, using the pan-neural elav-GAL4 driver
[47], affected both Eph expression patterns and medulla
architecture (Figure 8B). As can be seen in Figure 8B0, elav-
GAL4 driven expression of the reph
+ transgene effectively leveled
Eph expression throughout the medulla, eliminating the charac-
teristic gradient—this was most noticeable at the dorso-ventral
margins. As a consequence, medulla architecture was abnormal,
manifest as gaps in the medulla neuropil (arrowheads, Figure 8B9)
similar to those observed when Eph/Ephrin signaling was
disrupted in the eph
KD and ephrin
RS5 mutants. To refine the ectopic
expression approach, a ‘‘FLP-out’’ activated GAL4 driver,
P[tuba1.y+,CD8.GAL4 ] [48], was used to express UAS-reph
+ in
somatic cell clones (Figure 8C). Clones were positively marked by
the co-expression of UAS-CD8::GFP [49]. In specimens harboring
clones within the medulla, GFP-positive clones displayed en-
hanced Eph expression and were associated with areas of large
cortical inclusions (red arrowheads, Figures 8C9 and 8C0). Gaps
within the medulla neuropil, an indication of axon projection
defects, were also observed (yellow arrowhead, Figures 8C9and
8C0). Taken together, these data indicate that reph functions
upstream of Eph as a regulator of its expression.
Discussion
In vertebrates, the diverse array of Eph and Ephrin family
members contribute to many aspects of nervous system develop-
ment, notably axon guidance [1,3,50]. Surprisingly, although
expressed throughout the embryonic CNS [36,51] and larval
visual system [21], the contribution of the single D. melanogaster Eph
receptor/Ephrin ligand pair in terms of axon guidance and overall
nervous system development remains unclear. While RNAi knock-
down experiments have suggested a role for this pathway in axon
guidance [21,36], analyses of an Eph null allele have demonstrated
little to no role in axon guidance within either the developing
embryonic or larval nervous system but rather a specific
requirement for mushroom body development [22]. Since the
ephrin
RS5 and eph
KD mutants described in this paper exhibit axon
guidance defects reminiscent of RNAi-induced phenotypes, how
Eph/Ephrin signaling is translated into functional outcomes
remains unclear but would seem to depend on the nature of the
allele (e.g. null, forward-signaling inhibited, etc.). Thus, the 40
interacting loci that potentially encode Eph pathway components
recovered in the genetic screen described in this paper are likely to
help shed light in many areas of Eph/Ephrin signaling. One of
these, reph, encodes a putative nuclear factor that evidently
regulates Eph expression.
Identification of Eph/Ephrin-interacting molecules via
genetic screening
Using the now conventional modifier screen based on an
externally visible eye defect [23–25] we identified a group of
candidate genes encoding components of the Eph/Ephrin
signaling pathway. The SE phenotype used in this screen
(Figure 2B) presumably resulted from hyper-activation of Eph
signaling in the retina during development because it was
suppressed by co-expression of a C-terminal truncated, domi-
nant-negative Eph isoform or by the eph
KD mutation. Of the 52
modifiers recovered representing 40 loci, 24 carried lethal
mutations. Since eph null alleles are viable [22] it is likely that
the genes associated with these lethal mutations have additional
developmental functions distinct from their roles within the Eph/
Ephrin signaling pathway. Although many of the mutants (8/11
loci examined, data not shown) that survived to the late third instar
larval stage displayed optic lobe defects consistent with a role in
the Eph pathway, such phenotypes alone could not be used to
establish that the affected genes were components of the Eph/
Ephrin signaling pathway, given the diverse cellular processes and
molecular pathways involved in optic lobe development. There-
fore, evidence for genetic interaction between modifier mutations
and Eph/Ephrin mutants was investigated.
Allele-specific effects of Eph/Ephrin mutations on
Drosophila nervous system development
D. melanogaster encodes a single Eph receptor/Ephrin ligand
pair, expressed in the embryonic CNS, the developing visual
system (Figure 1) and the adult brain. Despite the simplicity of this
single pairing in D. melanogaster, the role of Eph/Ephrin signaling
with respect to nervous system development is surprisingly
complex. Although functional as a canonical receptor/ligand pair
when ectopically activated in both the embryonic CNS [22,36]
and developing visual system [21], Eph and Ephrin mutations,
exhibit both tissue selective and allele-specific effects, instead of
revealing a generalized role. Eph-null mutations [22] and a
mutation that deletes the Eph kinase domain (eph
KD; Figure 3) are
without discernible effect on the embryonic CNS. However, both
the eph
KD and ephrin
RS5 alleles exhibited defects in visual system
development (Figure 3). Surprisingly, prior examination of an Eph
null mutation did not reveal photoreceptor axon guidance defects
in the developing visual system [22]. However, a requirement for
Eph-signaling in the olfactory system is revealed by both Eph-null
and eph
KD mutants; axon guidance of mushroom body neurons is
affected in the Eph-null background [22] while eph
KD flies exhibit
defects in olfactory-based learning (A. Szybowski and S. Kunes,
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developmental abnormalities.
The distinctions between these observations may result from
underlying differences in the individual mutant genotypes and
together suggest that the degree of Eph-specific and Ephrin-
specific signaling plays a critical role in axon guidance outcomes.
Neither Eph nor Ephrin signaling would be activated in Eph-null
mutations, but the eph
KD allele encodes a truncated polypeptide
capable of activating Ephrin signaling. In vertebrates, kinase-
truncated Eph receptors are active as ligands for signaling through
Figure 7. reph loss-of-function suggests cell autonomous regulation of Eph expression. A requirement for reph in optic lobe development
was assessed by generating homozygous somatic reph
k8617A clones by the FLP, FRT method. Mutant clones were marked by loss of expression of an
arm-lacZ reporter (anti-bgal, red in B, blue in C and D). Overall optic lobe architecture was revealed by anti-HRP staining (green color in all panels,
shown alone in A9 and B9). A,A9,A0) A wild type specimen illustrating the normal distribution of Eph expression in the lamina. B,B9,B0) A specimen
harboring a homozygous reph
k8617A clone (white or yellow outlines) along the ventral margin of the lamina displayed reduced Eph expression (anti-
Eph, blue in B, shown alone in B0) and incomplete LF formation (red arrowhead in B9). To assess potential pleiotrophic effects of reph
k8617A on lamina
development, reph
k8617A clones were stained for dachshund, a marker of lamina neurogenesis (anti-Dac, red color in C and D, shown alone in C0 and
D0). C,C9,C0) A wild type specimen highlighting Dac expression in the lamina. D,D9,D0) In the specimen shown, a large reph
k8617A clone encompassed
most of the ventral lamina (yellow outline) indicated by loss of lac-Z staining (blue). Dac expression was normal within the clone. Dorsal is up and
ventral is down in all panels. Abbreviations: lamina (lam), lamina furrow (LF), lobula (lob). Yellow bars in A0–D0 indicate the position of the midline.
doi:10.1371/journal.pone.0037303.g007
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the D. melanogaster Ephrin [36]. Thus, activation of Ephrin
signaling while simultaneously inhibiting Eph signaling, as is the
case for the eph
KD allele, may produce developmental outcomes
distinct from failure to activate either arm of the receptor/ligand
pair as would be the case for Eph-null mutations. Indeed, the fact
that Eph and Ephrin can signal independently even within the
same cell [38] supports the notion that integration of these distinct
signaling arms may be critical determinants of Eph/Ephrin
signaling outcomes.
Defects in visual system development for eph
KD mutants were
qualitatively similar to, albeit less severe than, the loss-of-function
phenotype induced by RNAi knockdown of Eph [21], the most
consistent of which were defects in cortical axon guidance
(Figure 3). There were additional defects noted with eph
KD, such
as reduced viability and sterility; these phenotypes likely were not
detected in the prior analysis because they are also outcomes of
microinjection, which was used to introduce double-stranded
RNA. A synthesis of these observations indicates that cortical axon
guidance in the developing optic lobe requires the kinase-
dependent ‘forward’ signaling activity of Eph in the context of
simultaneous Ephrin activation. The abundance of cortical axon
guidance defects associated with putative Eph signaling mutants
(data not shown) supports this conclusion. Roles for Eph signaling
beyond axon guidance during nervous system development await
further elucidation. The slightly weaker, similar phenotypes
observed in the mutant ephrin
RS5 (Figure 3) are consistent with
the notion that Ephrin plays the role of ligand in the optic lobe,
inducing Eph kinase activity. While detailed characterization of
the eph
KD and ephrin
RS5 mutants remains, their moderate pheno-
types were well-suited to the purpose of screening for genetic
Figure 8. Ectopic misexpression of reph up-regulates Eph expression in the developing visual system. To determine whether reph
+ was
sufficient for Eph expression, the UAS, GAL4 system was used to drive expression of a UAS-reph
+ transgene in cell-specific patterns or within somatic
clones. GAL4-expressing cells and clones were positively marked by membrane-bound GFP expressed from a UAS-CD8::GFP transgene (green color in
B and C; shown alone in B9. The axonal architecture was visualized by staining with anti-HRP (green in A, red in C). A,A9,A0) A wild type specimen
showing the medulla and its characteristic high midline-low dorsoventral gradient of Eph (anti-Eph, blue in A, shown alone in A0). B,B9,B0) Expression
of UAS-reph
+ in cortical neurons using an elav-GAL4 driver flattens the Eph gradient, notably at the dorsoventral margins (anti-Eph, blue in B, shown
alone in B0). Defects in medulla development seen as gaps in the neuropil (yellow arrowheads in B9,B0) result from this up-regulation of Eph
expression. C,C9,C0) Several UAS-reph
+ cortical clones (red arrowheads in C9,C0) generated using a flip-out tubGAL4 driver can be seen in this specimen.
Within these clones, Eph expression (anti-Eph, shown alone in C0) was up-regulated. The enhanced Eph expression was associated with defects
manifest as large HRP
+ cortical inclusions. Disruption of the normal Eph expression pattern also affected medulla neuropil development (yellow
arrowhead in C9,C 0). Abbreviations: lobula (lob), medulla neuropil (med n).
doi:10.1371/journal.pone.0037303.g008
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genes.
Reph, a novel regulator of Eph expression
A suppressor mutant, designated here as reph (regulator of Eph
expression; Figure 5), exhibited genetic interactions with eph
KD and
ephrin
RS5 mutants (Figure 4), consistent with function in Eph/
Ephrin signaling. reph mapped to the region 24C2-24D2 by
complementation analyses using chromosomal deficiencies and
lethal P-element insertions localized reph to the CG3920 locus,
which encodes two transcript isoforms (Figure 5). Ectopic
expression of CG3920, in the form of a UAS-reph
+ transgene,
rescued reph mutant phenotypes, verifying the identity of reph as
CG3920. The single most prominent feature of Reph is the
presence of a nuclear localization sequence, P330RRRPSN336,
suggesting a putative nuclear protein. Alignment searches indicate
that Reph has similarities to a variety of transcription factors, such
as the human SPOC-D1 protein (Figure 5), although no obvious
homologues. Consistent with a role in transcription, Reph does
appear to act as a positive regulator of Eph expression in the optic
lobe.
All reph alleles, and heteroallelic combinations, were found to be
recessive or semi-lethal, with the majority of animals dying during
embryogenesis. The viability of both Eph-null mutations [22] and
eph
KD mutants (Figure 3) suggests that reph has additional functions
during embryonic development aside from the regulation of Eph
expression. Elucidating the extent of reph’s developmental role,
particularly the control of Reph expression itself, is of obvious
future interest.
Throughout the late third instar optic lobe, reph expression was
correlated with Eph expression (Figure 6), placing Reph in the
correct spatio-temporal context to regulate Eph expression. Both
the necessity and sufficiency of Reph in the regulation of Eph were
demonstrated via loss-of-function/gain-of-function experiments.
When reph function was eliminated in somatic clones, Eph
expression was reduced in a cell-autonomous fashion, whereas
strong ectopic reph
+ expression produced a cell-autonomous
increase in Eph expression. Both perturbations resulted in
developmental defects corresponding to the mutant clones
(Figures 7 and 8). It is unclear to what extent these observed
phenotypes generated by disruption of reph expression are
attributable to changes in Eph and how much might be due to
additional reph functions. The embryonic lethality of reph alleles,
but not eph nulls, suggests such additional reph functions.
Furthermore, reph expression within the medulla appears more
extensive than that of eph (Figure 6), which could indicate functions
outside of the Eph/Ephrin signaling pathway. However, the effects
of reph loss-of-function on optic lobe development were consistent
with established eph mutant phenotypes. Additionally, differenti-
ation of cells within reph somatic clones was normal, even though
Eph expression was decreased (Figure 7). These data indicate that,
at least in the optic lobe, reph is a novel regulator eph expression.
Regulation of Eph/Ephrin expression
Eph/Ephrin signaling has been most thoroughly characterized
in terms of growth cone dynamics. Less is known, by comparison,
about the regulation of Eph receptor and Ephrin ligand expression
patterns. Homeobox transcription factors regulate the expression
of EphA receptors during rhombomere boundary formation in the
vertebrate hindbrain [54–56] and developing retina [57]. Within
the optic tectum, engrailed family members regulate the expression
of Ephrins [58–60]. In the retina, the T-box transcription factor
Tbx5 and Vax homeodomain proteins reciprocally control the
expression of B-type Eph receptors and Ephrins along the dorsal-
ventral axis [61,62]. Homeobox genes also regulate EphB
receptors during vascular development [63]. The identification
of Reph expands the repertoire of transcriptional regulators of Eph
expression. Further study of Reph function is anticipated to shed
light on the regulation of Eph expression patterns, which is vital
given the numerous biological processes mediated by Eph/Ephrin
signaling in developing and adult tissues. We anticipate that the
identification and characterization of additional genes recovered
in the modifier screen will elucidate temporal-spatial specific
determinants governing Eph/Ephrin signaling outcomes and
facilitate a deeper understanding of the evolutionary conserved
mechanisms through which this receptor/ligand pair operates.
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